Prognostic Impact of Model for End-Stage Liver Disease Score in Patients Undergoing Liver Transplantation With Suboptimal Livers

Transplantation Proceedings

Volumn 39, Issue 6, 2007, Pages 1907-1909

  Vitale, A ^a   D'Amico, F ^b   Brolese, A ^b   Zanus, G ^b   Boccagni, P ^b   Neri, D ^b   Gringeri, E ^b   Valmasoni, M ^b   Ciarleglio, F A ^b   Carraro, A ^b   Pauletto, A ^b   Bonsignore, P ^b   Bassi, D ^b   Polacco, M ^b   D'Amico, D F ^b   Cillo, U ^b  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CAUSE OF DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; FATTY LIVER; FEMALE; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; KAPLAN MEIER METHOD; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SODIUM BLOOD LEVEL; STATISTICAL SIGNIFICANCE; SURVIVAL TIME;

ACUTE DISEASE; ADULT; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34547656002     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.05.032     Document Type: Article

References (10)

1. Harper A.M., Edwards E.B., and Eleison M.D. The OPTN waiting list, 1988-2000. Clin Transplant 16 (2001) 73
2. Wiesner R., Edwards E., Freeman R., et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124 (2003) 91
3. Pokorny H., Langer F., Herkner H., et al. Influence of cumulative number of marginal donor criteria on primary organ dysfunction in liver recipients. Clin Transplant 19 (2005) 532
4. Ploeg R.J., D'Alessandro A., Knechtle S.J., et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 55 (1993) 807
5. Onaca N.N., Levy M.F., Netto G.J., et al. Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant 3 (2003) 626
6. Moore D., Feurer I.D., Speroff T., et al. Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg 140 (2005) 273
7. Renz J.F., Kin C., Kinkhabwala M., et al. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg 242 (2005) 556
8. Briceno J., Marchal T., Padillo J., et al. Influence of marginal donors on liver preservation injury. Transplantation 74 (2002) 522
9. Ravioli M., Grazi G.L., Ercolani G., et al. Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. Transplantation 81 (2006) 525
10. Burroughs A.K., Sabin C.A., Rolles K., et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet 367 (2006) 225